Torbjorn Graslund

Stockholm, AB 14421, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma.

Peptide Nucleic Acid Probes for Pretargeted Affibody-Mediated Delivery of Cytotoxic Payloads to HER2-Positive Carcinoma.

Journal: Bioconjugate chemistry
Published: January 23, 2026

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Journal: International journal of biological macromolecules
Published: November 13, 2025

Correction: Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions.

Correction: Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions.

Journal: Biology direct
Published: July 16, 2025

Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions.

Affibodies as valuable tool to prevent β2m aggregation under lysosomal-like conditions.

Journal: Biology direct
Published: April 11, 2025

Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Journal: International journal of molecular sciences
Published: March 29, 2025

Heterogeneity in an adeno-associated virus transfection-based production process limits the production efficiency.

Heterogeneity in an adeno-associated virus transfection-based production process limits the production efficiency.

Journal: Scientific reports
Published: March 13, 2025

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.

Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.

Journal: EJNMMI radiopharmacy and chemistry
Published: March 10, 2025

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo.

An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo.

Journal: Translational oncology
Published: January 30, 2025

Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Affibody-Derived Drug Conjugates Targeting The Epidermal Growth Factor Receptor Are Potent And Specific Cytotoxic Agents.

Journal: ACS pharmacology & translational science
Published: January 29, 2025

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosis.

Journal: Cell
Published: January 29, 2025

Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model.

Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model.

Journal: ACS nano
Published: October 02, 2024

Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Affibody-Drug Conjugates Targeting the Human Epidermal Growth Factor Receptor-3 Demonstrate Therapeutic Efficacy in Mice Bearing Low Expressing Xenografts.

Journal: ACS pharmacology & translational science
Published: July 17, 2024
Showing 1-12 of 51

Last Updated: 09/26/2026